2-Chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → 1-{6-(3-Chloro-5-fluoro-4-hydroxyphenyl)-4-[4-(pyrrolidin-1-ylmethyl)piperidin-1-yl]quinolin-3-yl}-2-methylpropan-1-one
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12](=[O:16])[CH:13]([CH3:15])[CH3:14])=[C:5]2[N:17]1[CH2:22][CH2:21][CH:20]([CH2:23][N:24]2[CH2:28][CH2:27][CH2:26][CH2:25]2)[CH2:19][CH2:18]1.[Cl:29][C:30]1[CH:35]=[C:34](B2OC(C)(C)C(C)(C)O2)[CH:33]=[C:32]([F:45])[C:31]=1[OH:46]>>[Cl:29][C:30]1[CH:35]=[C:34]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12](=[O:16])[CH:13]([CH3:15])[CH3:14])=[C:5]3[N:17]2[CH2:18][CH2:19][CH:20]([CH2:23][N:24]3[CH2:25][CH2:26][CH2:27][CH2:28]3)[CH2:21][CH2:22]2)[CH:33]=[C:32]([F:45])[C:31]=1[OH:46]Participants
3
Reactant 2
Product 1
Procedure
Following general procedure D, 1-{6-bromo-4-[4-(pyrrolidin-1-ylmethyl)piperidin-1-yl]quinolin-3-yl}-2-methylpropan-1-one (30 mg, 0.068 mmol) was reacted with 2-chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (27 mg, 0.102 mmol) to afford the desired product (27.4 mg, 79%) as a yellow-brown solid: 1H NMR (500 MHz, CD3OD) δ 8.77 (s, 1H), 8.27 (d, J=1.8 Hz, 1H), 8.07-7.99 (m, 2H), 7.55-7.51 (m, 1H), 7.44 (dd, J=11.6, 2.2 Hz, 1H), 3.54-3.42 (m, 3H), 3.38-3.33 (m, 4H), 3.21-3.11 (m, 4H), 2.15-2.06 (m, 5H), 1.99 (d, J=11.0 Hz, 2H), 1.75-1.64 (m, 2H), 1.26 (d, J=6.9 Hz, 6H); ESI MS m/z 510 [C29H33ClFN3O2+H]+; HPLC 97.7% (AUC), tR=11.07 min.
Sources & evidence
- ORD record
- ord-a36c1fb9b23a45c292f35aebe8d9261d
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…